Susquehanna International Group, LLP Biotechnology

Susquehanna International Group, LLP

  • $688 Billion
  • Q2 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
ROIV
Roivant Sciences Ltd.
PUT
$4.82 Million
428K
Q2 2025
Reduced 48.78%
ABEO
Abeona Therapeutics Inc.
CALL
$4.71 Million
830K
Q2 2025
Reduced 92.76%
CPRX
Catalyst Pharmaceuticals, Inc.
PUT
$4.6 Million
212K
Q2 2025
Added 14.54%
VOR
Vor Biopharma Inc.
CALL
$4.54 Million
2.8M
Q1 2025
Added 234.09%
ACAD
Acadia Pharmaceuticals Inc
CALL
$4.53 Million
210K
Q2 2025
Reduced 52.69%
URGN
Uro Gen Pharma Ltd.
PUT
$4.34 Million
317K
Q2 2025
Added 426.84%
ALT
Altimmune, Inc.
CALL
$4.33 Million
1.12M
Q2 2025
Added 50.53%
VERA
Vera Therapeutics, Inc.
PUT
$4.31 Million
183K
Q2 2025
Reduced 39.21%
GLPG
Galapagos Nv
PUT
$4.2 Million
150K
Q2 2025
Reduced 33.73%
RVMD
Revolution Medicines, Inc.
PUT
$4.17 Million
113K
Q2 2025
Reduced 23.92%
PHAT
Phathom Pharmaceuticals, Inc.
PUT
$3.88 Million
405K
Q2 2025
Reduced 16.71%
IONS
Ionis Pharmaceuticals Inc
PUT
$3.84 Million
97.3K
Q1 2025
Added 175.52%
RYTM
Rhythm Pharmaceuticals, Inc.
CALL
$3.8 Million
60.2K
Q2 2025
Reduced 6.89%
ASND
Ascendis Pharma A/S
PUT
$3.75 Million
21.7K
Q1 2025
Reduced 61.84%
TVTX
Travere Therapeutics, Inc.
PUT
$3.57 Million
241K
Q2 2025
Reduced 10.93%
BEAM
Beam Therapeutics Inc.
CALL
$3.56 Million
209K
Q2 2025
Added 205.57%
AUPH
Aurinia Pharmaceuticals Inc.
CALL
$3.43 Million
405K
Q2 2025
Added 11.47%
PTCT
Ptc Therapeutics, Inc.
PUT
$3.34 Million
68.3K
Q2 2025
Added 307.04%
ALT
Altimmune, Inc.
PUT
$3.33 Million
860K
Q2 2025
Added 50.53%
ZLAB
Zai Lab LTD
CALL
$3.3 Million
94.5K
Q1 2025
Reduced 55.34%
ROIV
Roivant Sciences Ltd.
CALL
$3.24 Million
288K
Q2 2025
Reduced 48.78%
VRDN
Viridian Therapeutics, Inc.\De
PUT
$3.24 Million
232K
Q2 2025
Added 14.58%
RPRX
Royalty Pharma PLC
PUT
$3.21 Million
89.1K
Q2 2025
Reduced 67.97%
ITOS
I Teos Therapeutics, Inc.
PUT
$3.19 Million
320K
Q2 2025
Added 296.83%
SRRK
Scholar Rock Holding Corp
PUT
$3.15 Million
88.9K
Q2 2025
Reduced 39.46%
IMCR
Immunocore Holdings PLC
CALL
$3.09 Million
98.4K
Q2 2025
New holding
KALV
Kal Vista Pharmaceuticals, Inc.
CALL
$3.06 Million
271K
Q2 2025
Added 463.94%
CRMD
Cor Medix Inc.
PUT
$2.91 Million
237K
Q2 2025
Reduced 41.1%
PRTA
Prothena Corp Public LTD CO
PUT
$2.91 Million
480K
Q2 2025
Added 19.04%
APLS
Apellis Pharmaceuticals, Inc.
PUT
$2.87 Million
166K
Q2 2025
Added 1014.14%
ETON
Eton Pharmaceuticals, Inc.
CALL
$2.83 Million
199K
Q2 2025
Reduced 93.18%
BGNE
Bei Gene, Ltd.
PUT
$2.77 Million
12.2K
Q4 2024
Added 283.89%
AVXL
Anavex Life Sciences Corp.
PUT
$2.68 Million
291K
Q2 2025
Reduced 22.92%
XENE
Xenon Pharmaceuticals Inc.
PUT
$2.67 Million
85.3K
Q2 2025
New holding
IMVT
Immunovant, Inc.
CALL
$2.6 Million
94.5K
Q2 2025
Added 20.3%
CNTA
Centessa Pharmaceuticals PLC
CALL
$2.52 Million
192K
Q1 2025
Added 5612.59%
TRVI
Trevi Therapeutics, Inc.
CALL
$2.5 Million
457K
Q2 2025
Reduced 54.61%
XENE
Xenon Pharmaceuticals Inc.
CALL
$2.49 Million
79.6K
Q2 2025
New holding
SNDX
Syndax Pharmaceuticals Inc
PUT
$2.42 Million
258K
Q2 2025
Added 12.6%
KYMR
Kymera Therapeutics, Inc.
CALL
$2.41 Million
55.2K
Q2 2025
Reduced 9.9%
NUVB
Nuvation Bio Inc.
CALL
$2.36 Million
1.21M
Q2 2025
Added 58.8%
JANX
Janux Therapeutics, Inc.
PUT
$2.36 Million
102K
Q2 2025
Reduced 37.66%
KMPH
Kempharm, Inc
PUT
$2.36 Million
477K
Q2 2025
Reduced 2.37%
PRTA
Prothena Corp Public LTD CO
CALL
$2.33 Million
384K
Q2 2025
Added 19.04%
IBRX
Immunity Bio, Inc.
PUT
$2.32 Million
878K
Q2 2025
Added 139.43%
AVXL
Anavex Life Sciences Corp.
CALL
$2.22 Million
241K
Q2 2025
Reduced 22.92%
NTLA
Intellia Therapeutics, Inc.
CALL
$2.16 Million
230K
Q2 2025
Added 78.04%
REPL
Replimune Group, Inc.
CALL
$2.13 Million
229K
Q2 2025
Reduced 43.7%
RNA
Avidity Biosciences, Inc.
CALL
$2.09 Million
73.5K
Q2 2025
Reduced 8.87%
Filter Shares Options
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email